{"id":48416,"date":"2025-11-17T13:08:23","date_gmt":"2025-11-17T05:08:23","guid":{"rendered":"https:\/\/flcube.com\/?p=48416"},"modified":"2025-11-17T13:08:24","modified_gmt":"2025-11-17T05:08:24","slug":"changchun-genescience-secures-nmpa-approval-for-gs3%e2%80%91007a-dry-suspension-green%e2%80%91lights-gensci140-adc-trials","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=48416","title":{"rendered":"Changchun GeneScience Secures NMPA Approval for GS3\u2011007a Dry Suspension & Green\u2011lights GenSci140 ADC Trials"},"content":{"rendered":"\n

Changchun GeneScience Pharmaceutical Co., Ltd.<\/strong> announced two pivotal regulatory milestones from the China National Medical Products Administration (NMPA):<\/p>\n\n\n\n

    \n
  1. Clinical approval<\/strong> for GS3\u2011007a dry suspension<\/strong>, a Category\u202f1 oral small\u2011molecule growth\u2011hormone secretagogue indicated for pediatric growth\u2011hormone deficiency (PGHD).<\/li>\n\n\n\n
  2. Authorization to commence clinical trials<\/strong> for GenSci140<\/strong>, a bispecific antibody\u2011drug conjugate (ADC) targeting the \u03b1\u2011subtype of the folate receptor (FR\u03b1) in patients with locally advanced or metastatic solid tumours.<\/li>\n<\/ol>\n\n\n\n

    Regulatory Milestones<\/h2>\n\n\n\n
    Product<\/th>NMPA Decision<\/th>Indication<\/th>Drug Class<\/th>Approval\/Trial Start<\/th>Key Condition<\/th><\/tr><\/thead>
    GS3\u2011007a dry suspension<\/strong><\/td>Clinical approval (Category\u202f1)<\/td>Children\u2019s slow growth due to growth\u2011hormone deficiency (PGHD)<\/td>Small\u2011molecule secretagogue (oral)<\/td>17\u202fNov\u202f2025<\/td>Daily oral dosing<\/td><\/tr>
    GenSci140<\/strong><\/td>Trial\u2011initiation nod (Category\u202f1)<\/td>Advanced\/metastatic solid tumours (FR\u03b1\u2011positive & negative)<\/td>Bispecific ADC<\/td>17\u202fNov\u202f2025<\/td>Phase\u202fI\/II start within 30\u202fdays<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

    Product Profiles<\/h2>\n\n\n\n

    GS3\u2011007a Dry Suspension<\/h3>\n\n\n\n